providing expert intellectual property assistance to clients all over the world
since 2001
 |
 |
 |
Hotline: +49 (89) 23 23 67-0
Fax: +49 (89) 23 23 67-67
info@stolmar-ip.com
Blumenstr. 17
80331 München / goto googlemaps
Deutschland
weitere Standorte
Am 11. Oktober 2018 findet das 10. Innovation Forum Medizintechnik in Tuttlingen statt. Auch die Kanzlei Stolmár & Partner wird durch die die Patentanwälte Dr. Matthias Stolmár, der die Tuttlinger Zweigstelle leitet sowie Paul-Alexander Wacker dort vertreten sein.
Die Münchner Patentanwaltskanzlei Stolmár & Partner hat ein Büro im Kreis Tuttlingen in Neuhausen ob Eck eröffnet. Sie ist unter anderem auf Medizintechnik, Elektronik/ Software und Biotechnologie spezialisiert. Neben dem Hauptsitz in München hat Stolmár & Partner weitere Büros in Hamburg und in der Schweiz.
Stolmár & Partner is happy to announce that the European Medicines Agency (EMA) has granted orphan drug designation (EU/3/18/2008) on 16 April 2018 to Adeno-associated viral vector serotype 9 encoding miRNA against human superoxide dismutase 1 for the treatment of amyotrophic lateral sclerosis for its client Ecole Polytechnique Fédérale Lausanne (EPFL), Switzerland, where S & P acted as EU sponsor.
Yesterday, Intellectual Asset Management magazine publicly released its 2018 rankings of the IAM Patent 1000, listing Paul-Alexander Wacker among this distinguished class.
Paul-Alexander Wacker has been listed for several consecutive years among the IAM 1000. He now continues his appearance in the listings as of-counsel of Stolmár & Partner.
The IAM Patent 1000 provides a resource for identifying world-class patent attorneys in private practice. The quantitatively-evaluated listings account for depth of knowledge, market presence, level of work, and positive peer and client feedback.
For more information, please see Paul-Alexander Wacker’s full profile on the IAM 1000 website.
Zu lesen unter: